ストックスクリーナーアプリを入手
2.28
0.00%
0.00
アフターアワーズ：
2.22
-0.06
-2.63%
前日終値:
$2.28
開ける：
$2.28
24時間の取引高:
128.88K
Relative Volume:
0.35
時価総額：
$44.43M
収益：
-
当期純損益:
$-30.26M
株価収益率:
-1.1176
EPS:
-2.04
ネットキャッシュフロー:
$-24.69M
1週間 パフォーマンス:
-1.72%
1か月 パフォーマンス:
-14.93%
6か月 パフォーマンス:
+37.35%
1年 パフォーマンス:
-72.95%
1日の値動き範囲:
$2.21
$2.30
1週間の範囲:
$2.21
$2.3798
52週間の値動き範囲:
$1.11
$10.54
Annovis Bio Inc Stock (ANVS) Company Profile
名前
Annovis Bio Inc
セクター
電話
484-875-3192
住所
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
ANVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.28 | 45.40M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-10 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2024-10-25 | アップグレード | Maxim Group | Hold → Buy |
| 2023-12-29 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
Annovis Bio Inc (ANVS) 最新ニュース
Best data tools to analyze Annovis Bio Inc. stock2025 Key Highlights & Smart Swing Trading Alerts - Newser
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline - Investing.com
Annovis Bio: HC Wainwright Maintains Buy, PT Down to $10 from $12 - AInvest
Technical analysis overview for Annovis Bio Inc. stockForecast Cut & Expert Curated Trade Ideas - Newser
How to forecast Annovis Bio Inc. trends using time series2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright - TipRanks
Will Annovis Bio Inc. bounce back from current supportProduct Launch & Safe Entry Point Alerts - Newser
Annovis Bio Inc. recovery potential after sell offBear Alert & Weekly Top Gainers Alerts - Newser
Real time breakdown of Annovis Bio Inc. stock performanceWeekly Market Outlook & AI Powered Trade Plan Recommendations - Newser
Has Annovis Bio Inc. formed a bullish divergence2025 Big Picture & Technical Confirmation Alerts - Newser
Strategies to average down on Annovis Bio Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
What candlestick patterns are forming on Annovis Bio Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - Newser
What is the dividend yield of Annovis Bio Inc.2025 Support & Resistance & Entry Point Strategy Guides - khodrobank.com
What’s the profit margin of Annovis Bio Inc.July 2025 Technicals & Real-Time Buy Zone Alerts - khodrobank.com
Annovis Bio Inc. stock outlook for YEARMarket Rally & Smart Investment Allocation Tips - Newser
Risk adjusted return profile for Annovis Bio Inc. analyzedAnalyst Upgrade & Real-Time Stock Entry Alerts - Newser
Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference - citybuzz -
Forecasting Annovis Bio Inc. price range with options dataMarket Sentiment Summary & Weekly Momentum Stock Picks - Newser
How to escape a deep drawdown in Annovis Bio Inc.July 2025 Setups & Stepwise Trade Signal Implementation - Newser
Risk vs reward if holding onto Annovis Bio Inc.July 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Can Annovis Bio Inc. disrupt its industry2025 Trade Ideas & Weekly Market Pulse Updates - khodrobank.com
Neurodegenerative Disease Pioneer Annovis Bio to Showcase Progress at Major Investment Conference - Stock Titan
Regression analysis insights on Annovis Bio Inc. performanceDividend Hike & Safe Capital Growth Stock Tips - Newser
What is Annovis Bio Inc. s P E ratio telling usBull Run & Expert Approved Momentum Trade Ideas - khodrobank.com
Annovis Bio Inc. Hits Oversold Level on RSI Indicator getLinesFromResByArray error: size == 0 - kangso.co.kr
Parkinson’s Disease Pipeline Analysis, 2025 by DelveInsight | Annovis Bio, Cerevel Therapeutics, Roche, Inhibikase Therapeutics, Inc, Gain Therapeutics, Neuronascent, ANEW MEDICAL, Longevity Biotech, - Barchart.com
Key metrics from Annovis Bio Inc.’s quarterly dataEarnings Summary Report & Weekly High Potential Stock Alerts - Newser
Is Annovis Bio Inc. a turnaround storyMarket Risk Summary & Real-Time Stock Price Movement Reports - khodrobank.com
Applying chart zones and confluence areas to Annovis Bio Inc.2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Can Annovis Bio Inc. hit a new high this monthWatch List & Real-Time Buy Signal Alerts - Newser
Annovis Bio Inc. Hits Oversold Level on RSI IndicatorWeekly Stock Report & Weekly High Return Stock Forecasts - beatles.ru
Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio - MSN
Can a trend reversal in Annovis Bio Inc. lead to recovery2025 Key Lessons & Daily Technical Forecast Reports - Newser
Is Annovis Bio Inc. stock entering bullish territoryJuly 2025 Volume & Smart Allocation Stock Reports - Newser
Analyzing drawdowns of Annovis Bio Inc. with statistical toolsJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Developing predictive dashboards with Annovis Bio Inc. dataRate Cut & Weekly Breakout Watchlists - Newser
Will Annovis Bio Inc. Sustain Its Chart Breakout getLinesFromResByArray error: size == 0 - thegnnews.com
What moving averages say about Annovis Bio Inc.Weekly Loss Report & Daily Chart Pattern Signal Reports - Newser
Annovis Bio Inc (ANVS) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):